Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”
After decades of failures, researchers have renewed hopes for an effective HIV vaccine
Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”
How the little-known B and T cells can protect against COVID variants
Dr. Jennifer Lund explained the immune response to COVID.
A different type of COVID vaccine is about to roll around the world
Dr. Julie McElrath provided context about subunit protein vaccines, like those made by Novavax and Sanofi.
COVID vaccine immunity is waning — how much does that matter?
Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.
Long-haul COVID-19 can last months. But here’s why experts are optimistic about recovery.
Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.
A vaccine without needles? It’s on the way
Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.
Fred Hutch scientist answers latest COVID-19 questions on vaccines, variants, and more
GeekWire covered Fred Hutch’s Science Says virtual event where Hutch scientists discussed their latest work.
People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest
Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.
'It's history making:' Moderna's COVID-19 vaccine could be released this week
Dr. Jim Kublin reflected on progress in developing COVID-19 vaccines:
How to sign up for Seattle-area COVID vaccine trials
Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.
Roll up your sleeve to fight COVID-19: 3 new vaccine trials will start soon in the Seattle area
Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area.
Why volunteer for a vaccine study? Duty, love and a willingness to experiment, participants say
Dr. Jim Kublin discussed the need for volunteers in the COVID-19 clinical trial registry.
Immunology institute founded by Paul Allen shifts focus to tackle coronavirus
Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.
Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights
Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire.
Q&A: Millions of volunteers needed for COVID-19 vaccine trials
Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more.
On eve of first big coronavirus vaccine study, trial leaders brace for 'unprecedented' task
Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development.
Help wanted: Volunteers for COVID vaccine trials
Dr. Jim Kublin explained the CoVPN network, and the goals of the program.
Fred Hutch to lead COVID-19 vaccine trials
The CoVPN announcement is covered by KING 5.
First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic'
Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.
COVID-19 vaccine trials now open to volunteers in U.S.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Here's how to volunteer for a COVID-19 vaccine trial
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
Fred Hutch studies immune response to COVID-19, needs participants
Dr. Julie McElrath discussed the COVID Cohort study to gather information on first responders and those who are likely to be exposed to the virus.
The race to make vaccines faster
Andy McGuire commented on the vaccine development process in reference to COVID-19 vaccine research.
Dr. Julie McElrath on lifting physical distancing measures
Dr. Julie McElrath estimated when the COVID-19 outbreak will reach its peak and when we might see a lift on physical distancing measures.
Protecting against RSV
Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering.
Genetically engineered immune cells fight off deadly virus in mice
Science covered a B cell engineering study led by Dr. Justin Taylor.
Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study
GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses.
Local researchers progressing on malaria vaccine
Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center
Local researchers progressing on malaria vaccine
Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center
Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
New vaccine candidate could be the next step toward eliminating malaria
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Volunteers get bit to test new strategy for malaria vaccine
Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh
A genetically modified malaria vaccine has passed an important hurdle
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
New vaccine candidate could be the next step toward eliminating malaria
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Volunteers get bit to test new strategy for malaria vaccine
Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh
A genetically modified malaria vaccine has passed an important hurdle
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
An inside look at the labs where doctors intentionally infect people with malaria
Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch
An inside look at the labs where doctors intentionally infect people with malaria
Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
Charlie Sheen's HIV not likely a death sentence
Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division
Charlie Sheen's HIV not likely a death sentence
Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division